Effects of peroral insulin and glucose on circulating insulin-like growth factor-1, its binding proteins and thyroid hormones in neonatal calves.
There is disagreement in the literature about the ability of neonatal calves to absorb perorally administered insulin. This study evaluated the absorption of a bolus of insulin administered alone or with an energy souce and its effects on the circulating insulin-like growth factor system and thyroid hormones in newborn Holstein-Friesian calves. Within 1 h of dosing, mean serum insulin and triiodothyronine (T3) concentrations had increased considerably, whether the insulin was applied alone (n = 4) or together with glucose (n = 4), accompanied by marked hypoglycemia. No significant changes were observed in control calves (n = 4) given the vehicle solution. Increased serum glucose and T3 concentrations with no change in insulinemia occurred in a 4th group of calves given glucose alone. At 32 h of age and after 3 meals of colostrum there were no differences in glycemia, insulinemia, or proteinemia among the 4 groups of calves examined. Mean serum insulin-like growth factor-I (IGF-I) tended to decrease over this period in the control group. The decrease was more pronounced in the insulin-treated group but absent in both groups that received glucose. These differences were associated with equivalent differences in abundance of the 40-45K IGF-binding protein-3 (IGFBP-3); however, lower molecular mass IGFBPs were not affected. The results show that a pharmacological peroral dose of insulin can lead to rapid systemic alterations in the IGF/IGFBP system in neonatal calves that can be modified by simultaneous administration of a small energy supply in the form of glucose.
Kirovski
Danijela
D
Department of Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Belgrade, Belgrade Serbia. dani@vet.bg.ac.yu
Lazarević
M
M
Baricević-Jones
Ivona
I
Nedić
Olgica
O
Masnikosa
Romana
R
Nikolie
Judith Anna
JA
D000818:Animals; D000831:Animals, Newborn / Q000097:blood / Q000378:metabolism; D002417:Cattle / Q000097:blood / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D007328:Insulin / Q000097:blood / Q000493:pharmacokinetics*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism; D018969:Insulin-Like Growth Factor Binding Proteins / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D008970:Molecular Weight; D011897:Random Allocation; D013963:Thyroid Hormones / Q000097:blood*
D007328:Insulin; D018972:Insulin-Like Growth Factor Binding Protein 3; D018969:Insulin-Like Growth Factor Binding Proteins; D013963:Thyroid Hormones; D007334:Insulin-Like Growth Factor I; D005947:Glucose